Spry2 RNA in situ Gene Expression Assay

Gene Expression Data
Assay Details

Assay

Reference:	J:129202 Dunty WC Jr, et al., Wnt3a/beta-catenin signaling controls posterior body development by coordinating mesoderm formation and segmentation. Development. 2008 Jan;135(1):85-94
Assay type:	RNA in situ
MGI Accession ID:	MGI:7574741
Gene symbol:	Spry2
Gene name:	sprouty RTK signaling antagonist 2

Probe:	Spry2 probe
Probe preparation:	Antisense RNA

Results

Specimen not shown: embryonic day 8.5 (more

)

Structure	Level	Pattern	Image	Note
TS13: unsegmented mesenchyme	Present

Specimen not shown: embryonic day 8.5; Ctnnb1^tm2Kem/Ctnnb1^tm2Kem, Tg(T-cre)1Lwd/0 (more

)
Note: Conditional mutant.

Structure	Level	Pattern	Image	Note
TS13: unsegmented mesenchyme	Ambiguous			Little to no expression.

Specimen not shown: embryonic day 8.5; Ctnnb1^tm1Mmt/Ctnnb1⁺, Tg(T-cre)1Lwd/0 (more

)
Note: Conditional mutant.

Structure	Level	Pattern	Image	Note
TS13: paraxial mesenchyme	Present			Expression was upregulated and anteriorly expanded, compared with the wild-type.

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 03/25/2025 MGI 6.24